Basimglurant
Basimglurant (INN) (code names RG-7090, RO4917523) is a negative allosteric modulator of the mGlu5 receptor which is under development by Roche for the treatment of treatment-resistant depression (as an adjunct) and fragile X syndrome. As of August 2014, it is in phase II clinical trials for both of these indications.
primaryTopic
Basimglurant
Basimglurant (INN) (code names RG-7090, RO4917523) is a negative allosteric modulator of the mGlu5 receptor which is under development by Roche for the treatment of treatment-resistant depression (as an adjunct) and fragile X syndrome. As of August 2014, it is in phase II clinical trials for both of these indications.
has abstract
Basimglurant (INN) (code names ...... for both of these indications.
@en
ATC prefix
CAS number
802906-73-6
IUPAC name
2-chloro-4-{[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-yl]ethynyl}pyridine
@en
PubChem
thumbnail
Wikipage page ID
43,450,275
Wikipage revision ID
713,194,959
ChemSpiderID
molecular weight
3.25767e+2
smiles
StdInChIKey
UPZWINBEAHDTLA-UHFFFAOYSA-N
hypernym
comment
Basimglurant (INN) (code names ...... for both of these indications.
@en
label
Basimglurant
@en
